Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Reports Achieving Primary Objective in Mont Blanc, the First Phase 3 Glaucoma Trial for NCX 470

October 31, 2022

View Press Release Corporate presentation Contact us
Previous